Emerging Roles for LGR4 in Organ Development, Energy Metabolism and Carcinogenesis

Area of Science:

• Molecular biology
• Cellular signaling
• Medical research

Background:

• Leucine-rich repeats containing G protein-coupled receptor 4 (LGR4) is a member of the GPCR family.
• Aberrant LGR4 signaling is implicated in various diseases and carcinogenesis.
• LGR4 presents a potential therapeutic target for diseases and tumors.

Purpose of the Study:

• To provide a comprehensive overview of LGR4's molecular characteristics and signaling mechanisms.
• To explore LGR4's role in organ development, immunology, metabolic diseases, oxidative stress, and cancer progression.
• To highlight LGR4 as a promising target for novel drug development.

Main Methods:

• Literature review and synthesis of existing research on LGR4.
• Analysis of LGR4's involvement in diverse biological processes and disease pathways.
• Exploration of LGR4's therapeutic potential based on its functions.

Main Results:

• LGR4 exhibits diverse regulatory roles across multiple cell types and tissues.
• LGR4 signaling is significantly involved in the development of immunological and metabolic diseases.
• LGR4 plays a critical role in oxidative stress damage and cancer progression.

Conclusions:

• In-depth understanding of LGR4 and its ligands can enrich regulatory network knowledge.
• LGR4 targeted drug design holds promise for treating various diseases and tumors.
• GPCRs, including LGR4, represent a significant class of therapeutic targets for drug discovery.